The Detection of Post-Therapy Residual Minimal Disease in Leukemias Characterized by Specific Chromosomal Anomalies

The Detection of Residual Minimal Disease (RMD) in CML after Therapy: Kathryn E. Fuscaldo and Isadore Brodsky, Hahnemann University, Philadelphia, Pa. USA. Chromosomal and Southern Blot analyses have been used to diagnose Leukemias characterized by non-random chromosomal rearrangements. They have al...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia & lymphoma 1993, Vol.11 (s1), p.33-37
Hauptverfasser:	Fuscaldo, Kathryn E., Brodsky, Isadore
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Child Chromosome Aberrations DNA Probes Humans In Situ Hybridization, Fluorescence Leukemia - classification Leukemia - diagnosis Leukemia - genetics Leukemia - pathology Lymphoma - diagnosis Lymphoma - genetics Lymphoma - pathology Neoplasm Proteins - analysis Neoplasm Proteins - genetics Neoplastic Stem Cells - ultrastructure Polymerase Chain Reaction Post therapy residual minimal disease leukemias RNA, Messenger - analysis RNA, Neoplasm - analysis specific chromosomal anomalies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!